Glia, 2021 · DOI: 10.1002/glia.24019 · Published: September 1, 2021
Schwann cells can help repair spinal cord injuries, but many die after transplantation. This study explores ways to protect them using 'hypoxia-mimetics,' drugs that mimic the effects of low oxygen. The researchers found that these drugs, particularly deferoxamine (DFO) and adaptaquin (AQ), stabilized a protein called HIF-1α, which helps cells adapt to low oxygen conditions. Preconditioning Schwann cells with these drugs made them more resistant to oxidative stress, a major cause of cell death in neurological injuries. This suggests that using these drugs could improve the survival of transplanted Schwann cells and protect them in other neurological conditions.
Pharmacological preconditioning with DFO or AQ could enhance the survival rate of transplanted Schwann cells in spinal cord injury treatments.
The use of pharmacological agents like DFO is more easily adaptable to clinical-grade protocols compared to direct hypoxic preconditioning.
Hypoxia-mimetics may offer protection against oxidative stress-induced damage in other peripheral nervous system injuries and demyelinating diseases.